title: Nivolumab-associated vitiligo-like depigmentation in a patient with acute myeloid leukemia: A novel finding.
authors.affiliation: Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
authors.forename: Emily S
authors.initials: ES
authors.lastname: Yin
authors.affiliation: Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
authors.forename: Mariam B
authors.initials: MB
authors.lastname: Totonchy
authors.affiliation: Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
authors.forename: Jonathan S
authors.initials: JS
authors.lastname: Leventhal
keywords: AML, acute myeloid leukemia; PD-1, programmed cell death–1; adverse events; immunomodulators; immunotherapy; irAEs, immune-related adverse events; nivolumab; programmed cell death–1; vitiligo